Trial
NCT00226954
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
Novartis
Condition
Urologic Neoplasms
Intervention
zoledronic acid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-18